327 related articles for article (PubMed ID: 15214778)
1. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
2. Lead validation and SAR development via chemical similarity searching; application to compounds targeting the pY+3 site of the SH2 domain of p56lck.
Macias AT; Mia MY; Xia G; Hayashi J; MacKerell AD
J Chem Inf Model; 2005; 45(6):1759-66. PubMed ID: 16309282
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.
Llinaś-Brunet M; Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Betageri R; Cardozo M; Jakes S; Lukas S; Patel U; Proudfoot J; Moss N
J Med Chem; 1999 Feb; 42(4):722-9. PubMed ID: 10052978
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
6. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
Yamaguchi H; Hendrickson WA
Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
[TBL] [Abstract][Full Text] [Related]
9. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
Dutartre H; Harris M; Olive D; Collette Y
Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
[TBL] [Abstract][Full Text] [Related]
10. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
[TBL] [Abstract][Full Text] [Related]
11. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
[TBL] [Abstract][Full Text] [Related]
15. Growth transformation of human T cells by herpesvirus saimiri requires multiple Tip-Lck interaction motifs.
Heck E; Friedrich U; Gack MU; Lengenfelder D; Schmidt M; Müller-Fleckenstein I; Fleckenstein B; Ensser A; Biesinger B
J Virol; 2006 Oct; 80(20):9934-42. PubMed ID: 17005671
[TBL] [Abstract][Full Text] [Related]
16. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
Choi YB; Kim CK; Yun Y
J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Lck-binding elements in the herpesviral regulatory Tip protein.
Bauer F; Hofinger E; Hoffmann S; Rösch P; Schweimer K; Sticht H
Biochemistry; 2004 Nov; 43(47):14932-9. PubMed ID: 15554700
[TBL] [Abstract][Full Text] [Related]
18. P56lck: a transducing protein that binds to SH2 containing proteins and to phosphotyrosine containing proteins.
Ramos-Morales F; Douté M; Fischer S
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):695-700. PubMed ID: 7526919
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Lck tyrosine protein kinase by the Herpesvirus saimiri tip protein involves two binding interactions.
Hartley DA; Amdjadi K; Hurley TR; Lund TC; Medveczky PG; Sefton BM
Virology; 2000 Oct; 276(2):339-48. PubMed ID: 11040125
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
